REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 142 filers reported holding REPLIMUNE GROUP INC in Q2 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,196,165 | -4.9% | 186,801 | +29.1% | 0.02% | 0.0% |
| Q2 2023 | $3,359,748 | -12.2% | 144,692 | -33.2% | 0.02% | -26.9% |
| Q1 2023 | $3,826,551 | +87.9% | 216,679 | +189.3% | 0.03% | +52.9% |
| Q4 2022 | $2,037,008 | +59.0% | 74,890 | +1.0% | 0.02% | +21.4% |
| Q3 2022 | $1,281,000 | +28.9% | 74,147 | +30.3% | 0.01% | +55.6% |
| Q2 2022 | $994,000 | -41.7% | 56,884 | -43.4% | 0.01% | -10.0% |
| Q1 2022 | $1,705,000 | -8.0% | 100,431 | +46.9% | 0.01% | 0.0% |
| Q4 2021 | $1,853,000 | +0.2% | 68,389 | +9.6% | 0.01% | -23.1% |
| Q3 2021 | $1,849,000 | -29.7% | 62,372 | -8.8% | 0.01% | -23.5% |
| Q2 2021 | $2,629,000 | -12.1% | 68,427 | -30.2% | 0.02% | -15.0% |
| Q1 2021 | $2,991,000 | +362.3% | 98,032 | +478.4% | 0.02% | +233.3% |
| Q4 2020 | $647,000 | – | 16,949 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,050,187 | $53,866,302 | 35.13% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $37,055,978 | 5.02% |
| Redmile Group, LLC | 3,811,988 | $67,319,708 | 2.92% |
| Nan Fung Group Holdings Ltd | 189,339 | $3,343,727 | 2.28% |
| Altium Capital Management LP | 148,000 | $2,613,680 | 1.45% |
| Integral Health Asset Management, LLC | 395,000 | $6,975,700 | 1.40% |
| BVF INC/IL | 2,143,036 | $37,846,016 | 1.38% |
| Resolute Capital Asset Partners LLC | 82,500 | $1,457 | 1.06% |
| SECTORAL ASSET MANAGEMENT INC | 262,200 | $4,630,452 | 0.89% |
| Frazier Life Sciences Management, L.P. | 686,762 | $12,128,217 | 0.88% |